Alpine Associates Management’s Amedisys AMED Stock Holding History

Alpine Associates Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,096,920	Closed	-$108M	–	69
2025 Q2	$108M	Buy	1,096,920 +104,800	+11%	+$9.92M	5.78%	6
2025 Q1	$91.9M	Buy	992,120 +104,000	+12%	+$9.59M	4.81%	7
2024 Q4	$80.6M	Buy	888,120 +27,403	+3%	+$2.52M	4.9%	7
2024 Q3	$83.1M	Sell	860,717 -420,180	-33%	-$41M	3.81%	10
2024 Q2	$118M	Buy	1,280,897 +11,000	+0.9%	+$1.02M	5.65%	4
2024 Q1	$117M	Sell	1,269,897 -1,200	-0.1%	-$112K	4.56%	7
2023 Q4	$121M	Buy	1,271,097 +237,600	+23%	+$22.2M	6.2%	4
2023 Q3	$96.5M	Buy	1,033,497 +328,300	+47%	+$30.3M	5.06%	9
2023 Q2	$64.5M	Buy	+705,197	New	+$57.9M	2.9%	16

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return